Copley JB, Wüthrich RP. Therapeutic management of post‐kidney transplant
hyperparathyroidism. Clin Transplant 2011: 25: 24–39.© 2010 John Wiley & Sons A/S …

Abstract Purpose of Review Despite metabolic improvements following kidney
transplantation, transplant recipients still often suffer from complex mineral and bone …

Kidney transplantation, the most effective treatment for the metabolic abnormalities of
chronic kidney disease (CKD), only partially corrects CKD–mineral and bone disorders …

Background and objectives: Information on the time course of serum calcium levels after
renal transplantation is scanty, especially in the early posttransplantation period. Both the …

Hypercalcemia, occurring in up to 25% of patients within 12 months following renal
transplantation, and persistent hyperparathyroidism were evaluated following renal …

Evenepoel P, Sprangers B, Lerut E, Bammens B, Claes K, Kuypers D, Meijers B,
Vanrenterghem Y. Mineral metabolism in renal transplant recipients discontinuing cinacalcet …

Hypercalcemia (HC) has been variably reported in kidney transplanted (KTx) recipients (5–
15%). Calcium levels peak around the 3rd month after KTx and thereafter slightly reduce …

Background We aimed to longitudinally analyse changes in the levels of serum fibroblast
growth factor 23 (FGF23), intact parathyroid hormone (iPTH) and associated minerals in …

Experience from human renal allotransplantation informs us that disturbances in serum
calcium and phosphate levels are relatively common. Post‐transplant hypercalcemia is …

Background and objectives: Hypercalcemia is a common complication in renal transplant
recipients and has been associated with nephrocalcinosis and poor graft outcome. The …